| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| CVI Investments, Inc. | 7.7% | $1,284,000 | 10,700,000 | CVI Investments, Inc. | 03 Jan 2025 |
As of 31 Dec 2025, 1 institutional investors reported holding 1 shares of Bionano Genomics, Inc. - Common Stock, par value $0.0001 per share (BNGO). This represents 0% of the company’s total 138,961,039 outstanding shares.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 1 | $2 | $2.00 | 1 | |
| 2025 Q3 | 1 | $2 | $2.00 | 1 | |
| 2025 Q2 | 1 | $3 | +$3 | $3.00 | 1 |
| 2025 Q1 | 0 | $0 | -$1,693,509 | $2.00 | 0 |
| 2024 Q4 | 5,875,732 | $1,693,783 | -$84,666 | $0.29 | 41 |
| 2024 Q3 | 5,485,532 | $2,483,366 | -$1,082,119 | $0.45 | 49 |
| 2024 Q2 | 6,607,426 | $4,480,183 | +$918,263 | $0.68 | 52 |
| 2024 Q1 | 4,906,563 | $5,445,185 | -$3,025,598 | $1.11 | 57 |
| 2023 Q4 | 6,172,248 | $11,665,159 | +$790,503 | $1.89 | 67 |
| 2023 Q3 | 5,279,701 | $15,998,487 | +$15,998,486 | $3.03 | 52 |
| 2023 Q2 | 1 | $1 | $1.00 | 1 | |
| 2023 Q1 | 1 | $1 | $1.00 | 1 | |
| 2022 Q4 | 1 | $1 | $1.00 | 1 | |
| 2022 Q3 | 1 | $2 | $2.00 | 1 | |
| 2022 Q2 | 1 | $1 | $1.00 | 1 | |
| 2022 Q1 | 1 | $3 | $3.00 | 1 |